Back to Search
Start Over
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study
- Source :
- Diabetes, Obesity & Metabolism
- Publication Year :
- 2021
- Subjects :
- Blood Glucose
medicine.medical_specialty
Glycated Hemoglobin A
COVID-19 Vaccines
Coronavirus disease 2019 (COVID-19)
COVID-19 Vaccine
Endocrinology, Diabetes and Metabolism
MEDLINE
Type 2 diabetes
Glycemic Control
Affect (psychology)
Endocrinology
Immunogenicity, Vaccine
Internal medicine
Research Letter
Internal Medicine
medicine
Humans
In patient
Poor glycaemic control
Glycated Hemoglobin
business.industry
Immunogenicity
COVID-19
medicine.disease
Research Letters
Vaccination
Diabetes Mellitus, Type 2
business
Human
Subjects
Details
- ISSN :
- 14631326
- Volume :
- 24
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Diabetes, obesitymetabolism
- Accession number :
- edsair.doi.dedup.....272b4021eab1783ca0800855b22e0672